Clinical Study

Evaluation of the Macular, Peripapillary Nerve Fiber Layer and Choroid Thickness Changes in Behçet’s Disease with Spectral-Domain OCT

Table 4

RNFL of patients with BD and controls.

VariablesGroupsOcular Involvement
Control ( )Behcet ( ) Present ( )Absent ( )

T72.42 ± 14.2371.21 ± 12.70.54176.86 ± 15.572.29 ± 11.220.212
Ts138.65 ± 18.8133.46 ± 24.180.116132.38 ± 37.45137.41 ± 19.860.518
Ns112.43 ± 20.87109.1 ± 20.250.27496.1 ± 14.95106.53 ± 18.140.031
N73.45 ± 14.8574.55 ± 13.830.60366 ± 12.7778.41 ± 13.710.002
Ni114.39 ± 24.06109.73 ± 25.010.202100.38 ± 27.64111.91 ± 21.550.087
Ti145.16 ± 23.26140.92 ± 23.550.223133.05 ± 19.21147.31 ± 24.830.028
G100.23 ± 10.0198.13 ± 11.140.18693.52 ± 10.19100.74 ± 10.640.016

Values are expressed as mean ± SD; : number of case; T: Temporal; Ts: Temporal Superior; Ns: Nasal Superior; N: Nasal; Ni: Nasal Inferior; Ti: Temporal inferior; G: average.